Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: A short-term study

被引:77
作者
Chen, Christine Y.
Wong, Tien Y.
Heriot, Wilson J. [1 ]
机构
[1] Eye Surg Assoc, Cabrini Med Ctr, Malvern, Vic 3144, Australia
[2] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia
[3] Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia
关键词
D O I
10.1016/j.ajo.2006.10.004
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To report the short-term study of intravitreal bevacizurnab (Avastin) in the treatment of neovascular age,related macular degeneration (AMD). DESIGN: Interventional, consecutive, prospective case series. METHODS: One hundred and two eyes of 102 patients with neovascular AMD received monthly intravitreal bevacizumab (Avastin) (1.25 mg) until resolution of macular edema, subretinal fluid, and/or pigment epithelial detachment. Outcome measures included visual acuity (VA) and central retinal thickness as defined from optical coherence tomography (OCT). RESULTS: Mean VA was 20/80 and OCT central retinal thickness was 251.0 +/- 74.6 mu m before injection and improved to 20/63 and 214.9 +/- 41.7 mu m at six weeks (P < .001), 20/50 and 204.8 +/- 33.6 mu m at 10 weeks (P < .001), and remained stable at 20/50 and 210 mu m after 14 weeks (P < .05). No significant ocular or systemic side effects were observed. CONCLUSIONS: Intravitreal bevacizumab (Avastin) appears to be beneficial and well tolerated in the treatment of neovascular AMD in the short term. Further comparative evaluation against other antivascular endothelial growth factor (VEGF) agents and dosing schedule is warranted.
引用
收藏
页码:510 / 512
页数:3
相关论文
共 5 条
[1]   Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration [J].
Avery, RL ;
Pieramici, DJ ;
Rabena, MD ;
Castellarin, AA ;
Nasir, MA ;
Giust, MJ .
OPHTHALMOLOGY, 2006, 113 (03) :363-372
[2]   Short-term safety and efficacy of intravitreal bevacizumab (avastin) for neovascular agerelated macular degeneration [J].
Rich, Ryan M. ;
Rosenfeld, Philip J. ;
Puliafito, Carmen A. ;
Dubovy, Sander R. ;
Davis, Janet L. ;
Flynn, Harry W., Jr. ;
Gonzalez, Serafin ;
Feuer, William J. ;
Lin, Richard C. ;
Lalwani, Geeta A. ;
Nguyen, Jackie K. ;
Kumar, Gaurav .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (05) :495-511
[3]   Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration [J].
Rosenfeld, PJ ;
Moshfeghi, AA ;
Puliafito, CA .
OPHTHALMIC SURGERY LASERS & IMAGING, 2005, 36 (04) :331-335
[4]   Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration [J].
Spaide, Richard F. ;
Laud, Ketan ;
Fine, Howard F. ;
Klancnik, James M., Jr. ;
Meyerle, Catherine B. ;
Yannuzzi, Lawrence A. ;
Sorenson, John ;
Slakter, Jason ;
Fisher, Yale L. ;
Cooney, Michael J. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (04) :383-390
[5]  
2006, PRELIMINARY RESULTS